These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
230 related articles for article (PubMed ID: 10417435)
1. Effectiveness of a new therapeutic regimen with albendazole in cutaneous larva migrans. Veraldi S; Rizzitelli G Eur J Dermatol; 1999; 9(5):352-3. PubMed ID: 10417435 [TBL] [Abstract][Full Text] [Related]
2. One-week therapy with oral albendazole in hookworm-related cutaneous larva migrans: a retrospective study on 78 patients. Veraldi S; Bottini S; Rizzitelli G; Persico MC J Dermatolog Treat; 2012 Jun; 23(3):189-91. PubMed ID: 21294643 [TBL] [Abstract][Full Text] [Related]
3. Albendazole: a new therapeutic regimen in cutaneous larva migrans. Rizzitelli G; Scarabelli G; Veraldi S Int J Dermatol; 1997 Sep; 36(9):700-3. PubMed ID: 9352416 [TBL] [Abstract][Full Text] [Related]
4. Single dose of albendazole in the treatment of cutaneous larva migrans. Orihuela AR; Torres JR Arch Dermatol; 1990 Mar; 126(3):398-9. PubMed ID: 2310216 [No Abstract] [Full Text] [Related]
5. Treatment of cutaneous larva migrans with albendazole. Preliminary report. Torres JR; Orihuela AR; Garcia D; Abdul-Hadi S Rev Inst Med Trop Sao Paulo; 1989; 31(1):56-8. PubMed ID: 2814206 [TBL] [Abstract][Full Text] [Related]
6. [The treatment of the cutaneous larva migrans syndrome with albendazole. The authors' experience]. Marangi M; Sanguigni S; Cultrera R; Fratto N; Teggi A; Martire F; De Rosa F Medicina (Firenze); 1990; 10(3):291-2. PubMed ID: 2079882 [TBL] [Abstract][Full Text] [Related]
7. [Current therapeutic possibilities in cutaneous larva migrans]. Wolf P; Ochsendorf FR; Milbradt R Hautarzt; 1993 Jul; 44(7):462-5. PubMed ID: 8365881 [TBL] [Abstract][Full Text] [Related]
8. Use of liquid nitrogen and albendazole in successfully treating cutaneous larva migrans. Kapadia N; Borhany T; Farooqui M J Coll Physicians Surg Pak; 2013 May; 23(5):319-21. PubMed ID: 23673168 [TBL] [Abstract][Full Text] [Related]
9. Treatment of cutaneous gnathostomiasis with ivermectin. Kraivichian K; Nuchprayoon S; Sitichalernchai P; Chaicumpa W; Yentakam S Am J Trop Med Hyg; 2004 Nov; 71(5):623-8. PubMed ID: 15569795 [TBL] [Abstract][Full Text] [Related]
10. [Cutaneous larva migrans in Turkey: an imported case report]. Sönmezer MÇ; Erdinç Ş; Tülek N; Babür C; Büyükdemirci A; İlgar T; Ertem G Mikrobiyol Bul; 2017 Jan; 51(1):94-99. PubMed ID: 28283015 [TBL] [Abstract][Full Text] [Related]
11. High efficacy of albendazole-PEG 6000 in the treatment of Toxocara canis larva migrans infection. Leonardi D; Echenique C; Lamas MC; Salomon CJ J Antimicrob Chemother; 2009 Aug; 64(2):375-8. PubMed ID: 19497941 [TBL] [Abstract][Full Text] [Related]
12. A randomized trial of ivermectin versus albendazole for the treatment of cutaneous larva migrans. Caumes E; Carriere J; Datry A; Gaxotte P; Danis M; Gentilini M Am J Trop Med Hyg; 1993 Nov; 49(5):641-4. PubMed ID: 8250105 [TBL] [Abstract][Full Text] [Related]
13. Treatment of larva migrans syndrome with long-term administration of albendazole. Hombu A; Yoshida A; Kikuchi T; Nagayasu E; Kuroki M; Maruyama H J Microbiol Immunol Infect; 2019 Feb; 52(1):100-105. PubMed ID: 28754237 [TBL] [Abstract][Full Text] [Related]
14. An unusual recurrence of pruritic creeping eruption after treatment of cutaneous larva migrans in an adult Ghanaian male: a case report with a brief review of literature. Quashie NB; Tsegah E Pan Afr Med J; 2015; 21():285. PubMed ID: 26587135 [TBL] [Abstract][Full Text] [Related]